FDA Cleared Depression Treatment
Treatment without Medication

Non Invasive Transcranial Magnetic / Direct current Stimulation Systems from the world leaders in transcranial direct current and magnetic stimulation.

Transcranial Magnetic Stimulation (TMS)

We offer a wide range of simulators and coils for clinical applications. We always had a first mover advantage, developing clinical solutions. The MagPro R 20 is upgradable to delivery 100Hz, and the MagPro R 30 is upgradable from 30Hz to 80Hz and to deliver THETA Burst protocol.

MagVita TMS Therapy – FDA Cleared Depression Treatment

TMS treatment of Major Depressive Disorder. The system is easy to use, it has low operating costs and provides high power stimulation. It has been especially designed for therapeutic use and can be used in both small and large clinics.

The complete MagVita TMS Therapy® system with TMS device (the stimulator), treatment chair, coils, isolation transformer, vacuum pump and pillow.

Simple treatment procedure

The MagVita TMS Therapy® treatment protocol consists of repeated cycles of rTMS followed by rest periods. A full MagVita TMS Therapy® consists of an initial session which includes the determination of the patient’s individual stimulation level (motor threshold determination), 5 treatment sessions per week over a period of 6 weeks.

Who can get MagVita TMS Therapy?

MagVita TMS Therapy® is FDA cleared for “treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode”.

How to get started with TMS depression treatment

MagVita TMS Therapy system® is an easy-to-use complete system for effectively treating depression. MagVita TMS Therapy® can perform repetitive Transcranial Magnetic Stimulation (rTMS) and run many protocols successively (up to 20.000 pulses). Once you have been trained by MagVenture, you are ready to offer the treatment.

Other Applications

Anxiety

“Anxiety disorders” is a broad term covering Generalized Anxiety Disorder, Phobic Disorder, and Panic Disorder. Approximately 15 % of the European population and 18 % of the American population are affected by an anxiety disorder.

Bulimia nervosa

Bulimia nervosa is an eating disorder characterized by periodically consuming a large amount of food in a short amount of time followed by an attempt to rid oneself of the food consumed, typically by vomiting, taking a laxative or diuretic, and/or excessive exercise. Bulimia nervosa is more likely to occur in women than men.

Migraine

Migraine is a chronic disorder with recurrent headaches often in association with a number of autonomic nervous system symptoms. Typically the headache is unilateral (affecting one half of the head) and pulsating in nature, lasting from 2 to 72 hours.

Rehabilitation

Rehabilitation of sensory and cognitive function typically involves methods for retraining neural pathways or training new neural pathways to regain or improve neurocognitive functioning that has been diminished by disease or trauma.

Schizophrenia – auditory hallucinations

Auditory hallucination is the false perception of sounds. A common form involves hearing one or more voices, which is often associated with psychotic disorders such as schizophrenia. Despite intensive treatment with antipsychotic medication, the auditory hallucinations often persist.

MagPro R20
The basic Transcranial Magnetic Stimulator for repetitive stimulation, upgradable upto 100Hz.

MagPro R30
Performance and ease of use rTMS stimulator for clinical use or clinical research. Upgradable to 60Hz, 80Hz or THETA Burst.

MagPro R100
The optimal solution for research within rehabilitation

Coils

MCF-B70 Butterfly Coil

MCF-B65 Butterfly Coil

Cool D-B80 Butterfly Coil

C-100 Circular coil

Transcranial Direct Current Stimulation (tDCS)

Soterix Medical 1×1 Platforms

The 1×1 platform stimulators are the most precise stimulators ever made for non-invasive electrical stimulation, including unique control features not available on any other products.

PainX tDCS System

PainX™ tDCS System is a completely new, safe and effective treatment for fibromyalgia and migraine. Originally invented and developed by a team of doctors and engineers at Soterix Medical, PainX™ is a non-invasive treatment.

Fibromyalgia

50% Or More Reduction in Pain in 50% of subjects

Clinical trial from Harvard Medical Schools shows dramatic Fibromyalgia pain relief starting in just two weeks, with no significant side-effects.*

The PainX™ external tDCS therapy system is safe and convenient, offering users a non-invasive treatment that is effective in reducing or eliminating the symptoms of Fibromyalgia. After just a few in-office treatments migraine sufferers can expect to feel relief.

Migraine

37% Or More Reduction in Pain with less and shorter attacks

Starting in just four weeks, effectiveness greater than pharmacological drugs with minimal side effects.*

The PainX™ tDCS therapy system is safe and convenient, offering users a non-invasive treatment that is effective in reducing or eliminating migraines. After just a few in-office treatments migraine sufferers can expect to feel relief.

Treating Fibromyalgia and Migraine with PainX™?

The PainX™ system was developed by leading doctors across the world. PainX™ is painless and you can engage in other activities during the treatment. Each treatment session lasts less than 30 minutes.You can expect to start feeling better after only a few sessions. Maximum benefit may take several weeks. If after stopping therapy your pain returns, you can return to your doctor for maintenance sessions.

Treatment of Migraine and Fibromyalgia with PainX™ is easy. Wires connect the device to electrode patches that are positioned on the patient’s head. A special cap or a strap ensures the patches are positioned at the correct location. Side effects are very mild and include skin redness and some itching that stops right after the session. After the session you can go about your regular activities at home and at work.

Depression LTE System

Depression™ tDCS-LTE System is a non-invasive medical device that stimulates the brain via electrodes on the scalp. It is a safe and effective in-office treatment for Depression.

Effective Treatment

34% symptom reduction in Major Depression

tDCS-LTE offers a non-invasive, sedation free, and seizure-risk free approach for the treatment of major depression, with virtually no side effects.

Lasting Benefit

1 month of sustained antidepressant response post-stimulation

tDCS-LTE delivers optimized and personalized stimulation. The most effective and tolerated stimulation requires intelligent tDCS-LTE technology.

Treating Major Depression with tDCS-LTE™?

The tDCS-LTE™ system was developed by leading doctors across the world. tDCS-LTE™ is painless and you can engage in other activities during the treatment. Each treatment session lasts around 20 minutes. You can expect to start feeling better after only a few sessions. Maximum benefit may take several weeks. If after stopping therapy your symptoms return, you can return to your doctor for maintenance sessions.

Treatment of depression with tDCS-LTE™ is easy. Wires connect the device to electrode patches that are positioned on the patient’s head. A special cap or a strap ensures the patches are positioned at the correct location. Side effects are very mild and include skin redness and some itching and tingling that stops right after the session. After the session you can go about your regular activities at home and at work.